scholarly journals Repeat Cardiovascular Risk Assessment after Four Years: Is There Improvement in Risk Prediction?

PLoS ONE ◽  
2016 ◽  
Vol 11 (2) ◽  
pp. e0147417 ◽  
Author(s):  
Parinya Chamnan ◽  
Rebecca K. Simmons ◽  
Stephen J. Sharp ◽  
Kay-Tee Khaw ◽  
Nicholas J. Wareham ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Cardiovascular Risk ◽  
Risk Prediction ◽  
Cardiovascular Risk Assessment

Cardiovascular Risk Assessment in Hypertensive Patients

2021 ◽  
Author(s):  
Michael C Wang ◽  
Donald M Lloyd-Jones
Keyword(s):  
Blood Pressure ◽  
Risk Assessment ◽  
Cardiovascular Risk ◽  
Risk Prediction ◽  
Clinical Management ◽  
Prognostic Significance ◽  
Quantitative Risk Assessment ◽  
Cardiovascular Risk Assessment ◽  
Hypertensive Patients ◽  
Cardiovascular Risk Prediction

Abstract Hypertension is a highly prevalent and causal risk factor for cardiovascular disease (CVD). Quantititaive cardiovascular risk assessment is a new paradigm for stratifying hypertensive patients into actionable groups for clinical management and prevention of CVD. The large heterogeneity in hypertensive patients makes this evaluation complex, but recent advances have made CV risk assessment more feasible. In this review, we first describe the prognostic significance of various levels and temporal patterns of blood pressure. We then discuss cardiovascular risk prediction equations and the rationale of taking global risk into account in hypertensive patients. Finally, we review several adjunctive biomarkers that may refine risk assessment in certain patients. We observe that, beyond individual cross-sectional measurements, both short-term and long-term blood pressure patterns are associated with incident CVD; that current cardiovascular risk prediction performs well, and its incorporation into hypertension management is associated with potential population benefit; and that adjunctive biomarkers of target organ damage show the most promise in sequential screening strategies that target biomarker measurement to patients in whom the results are most likely to change clinical management. Implementation of quantitative risk assessment for CVD has been facilitated by tools and direct electronic health record integrations that make risk estimates accessible for counseling and shared decision making for CVD prevention. However, it should be noted that treatment does not return an individual to the risk of someone who never develops hypertension, underscoring the need for primordial prevention in addition to continued innovation in risk assessment.

scholarly journals Cardiovascular Risk Assessment Among Urban Population of Bangladesh Using WHO/ISH Risk Prediction Chart.

2015 ◽  
Vol 44 (suppl_1) ◽  
pp. i202-i202 ◽  
Author(s):  
M. S. A. M. Ahmed ◽  
M. Moniruzzaman ◽  
S. Chowdhury ◽  
P. C. Banik
Keyword(s):  
Risk Assessment ◽  
Cardiovascular Risk ◽  
Risk Prediction ◽  
Urban Population ◽  
Cardiovascular Risk Assessment

scholarly journals Cardiovascular Risk Assessment Using WHO/ISH Risk Prediction Charts In a Rural Area of North India

2016 ◽  
Vol 4 (2) ◽  
pp. 127
Author(s):  
Priya Bansal ◽  
Anurag Chaudhary ◽  
Praneet Wander ◽  
Mahesh Satija ◽  
Sarit Sharma ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Cardiovascular Risk ◽  
Rural Area ◽  
Risk Prediction ◽  
North India ◽  
Cardiovascular Risk Assessment

scholarly journals Cardiovascular Risk Assessment among Postmenopausal Women: A Review

2018 ◽  
Author(s):  
Lingkan Barua ◽  
Mithila Faruque ◽  
Palash C Banik ◽  
Liaquat Ali
Keyword(s):  
Risk Factors ◽  
Risk Assessment ◽  
Cardiovascular Risk ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Postmenopausal Women ◽  
Risk Prediction ◽  
Assessment Tool ◽  
Hormone Replacement ◽  
Cardiovascular Risk Assessment

Cardiovascular diseases (CVD) are rising rapidly among the postmenopausal woman but they are less likely to identify their risk by an appropriate risk assessment tool. This review evaluates available literature on cardiovascular risk assessment among postmenopausal women to provide a concise view of risk factors and disease burden among them, present risk assessment systems including their drawbacks, emergence of new risk factors and their role in risk prediction, and finally use of hormone replacement therapy during menopause. Results demonstrate that menopause is a transition point for developing CVD not due to physiological changes only but psychosocial factors like depression and marital stress are also responsible. Both conventional and emerging risk factors burden are high among postmenopausal women. Though data regarding CVD risk assessment among postmenopausal population is lacking but existing evidences claimed underestimation or overestimation of risk among women. Moreover application of different tools on same population has revealed significant variation in result. In this regard, recalibration of conventional tools with local data and new risk factors has showed improvement of risk prediction. Hormone replacement therapy during early menopause has reported beneficial to prevent CVD but in secondary prevention it has no role. All of these findings demand further studies on cardiovascular risk assessment, especially in developing countries where women after menopause are not in consideration of health strategy makers.

Atherosclerotic cardiovascular risk assessment score in diabetes patients: a retrospective analysis of clinical data

2017 ◽  
Author(s):  
Sanjiv Shah ◽  
Jayaprakashsai Jana ◽  
Balaji Jaganmohan ◽  
Raja Selvarajan ◽  
SG Moazam ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Cardiovascular Risk ◽  
Retrospective Analysis ◽  
Clinical Data ◽  
Cardiovascular Risk Assessment ◽  
Assessment Score ◽  
Diabetes Patients
Sign in / Sign up

Export Citation Format

Share Document